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Another piece in the hypermutation puzzle
Studies with transgenic mice are beginning to define the minimal
requirements for the somatic hypermutation of immunoglobulin
genes that is critical in the production of high-affinity antibodies.
One of the hallmarks of an advanced vertebrate immune
system is the ability of the body to remember an invading
organism, and to educate itself to respond more vigor-
ously upon a second 'antigenic' challenge by the same
organism. After first contact with an antigen, a portion of
the responding B cells migrate to the germinal centers of
lymphoid organs, where they undergo a fantastic evolu-
tion. The B cells hypermutate their rearranged
immunoglobulin variable genes and undergo a process of
natural selection, whereby the clones that produce anti-
bodies with the highest affinity survive while other
clones die [1]. This results in 'memory' B cells, which
have 102 to 103 times higher affinity for the cognate anti-
gen than do the cells in the original clone. In two weeks,
this breathtaking process creates a million years' worth of
mutation and selection in a somatic recapitulation of evo-
lution. Over the last decade, our knowledge of this
process has grown considerably, although often the results
may seem confusing or contradictory. The published data
are like pieces of a dauntingly complex biological puzzle;
only recently have a few pieces, here and there, begun to
fit together to give us a view of the molecular mecha-
nism driving hypermutation.
We now know that the hypermutation occurs only at
the 5' end of immunoglobulin genes, centering on the
rearranged variable (V), diversity (D) and joining J) gene
segments. The mutations appear to be randomly distrib-
uted over a 2 kb region with a well-defined 5' end, start-
ing in the promoter region, and an amorphous 3' end
trailing into the intron downstream of the V(D)J coding
region [2]. Work from several laboratories [3-7] has linked
the immunoglobulin-gene mutation frequency with the
presence of both the intronic transcriptional 'enhancer'
element between the V(D)J and constant (C) regions and
the 3' enhancer downstream of the C region (Fig. 1). This
suggests that mutation correlates with an 'open' DNA
structure, associated with the potential for transcription.
There is, however, no evidence directly connecting
hypermutation to the transcription rate. Furthermore,
hypermutation appears to occur only in germinal-center
B cells [8], which express low levels of immunoglobulin
mRNA and cytoplasmic immunoglobulin [9,10]. The
role of the enhancers and transcription may therefore be
merely permissive, opening the gene to make it accessible
to the hypermutation machinery.
This leaves unanswered the question of the cis DNA
sequences which target the hypermutation machinery to
the 5' end of the rearranged immunoglobulin gene.
While the epicenter of mutation is the V(D)J region, the
targeted area is skewed downstream into the V/C intron,
and trails off after about 1 000 bases. At the 5' end, muta-
tions end much more abruptly, in that they occur over a
300 bp region and are not usually found upstream of the
promoter. Although evidence from several laboratories
has suggested that the promoter and/or the rearranged
V(D)J gene are involved in targeting the mutation mech-
anism, recent experiments by Neuberger, Milstein, and
their colleagues [11,12] indicate that neither the V7 gene
nor the immunoglobulin gene promoter are required for
hypermutation.
Last year, Betz et al. [11] reported that, whereas the
intronic enhancer and the 3' enhancer were specifically
needed to produce somatic hypermutation of a K light
Fig. 1. Transgene constructs used to
investigate the cis DNA sequence
requirements for somatic hypermutation.
The first four constructs were made by
Betz et al. [11]: the first is similar to the
endogenous rearranged K chain locus;
the second and third are deletion con-
structs, with either the 3' or intronic
enhancer (E) removed. In the fourth con-
struct, the K promoter (P) has been
replaced with the P-globin promoter
(13P). The final three constructs were
made by Yelamos et al. 112], and in these
cases the V region has been replaced by
other sequences (gpt and neo, bacterial
genes; P3G, human -globin gene). The
mutation rates of each construct are
given as percentages relative to that of
the first construct. (L, leader sequence.)
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chain transgene, the immunoglobulin gene promoter was
not. They removed the K promoter, the transcription start
site and the 5' nontranslated region, and replaced it with
the corresponding section of the P-globin gene promoter
(Fig. 1). Although the modified transgene had one-third
fewer mutations compared with the original construct, it
was still able to undergo hypermutation. Taken together
with previous results, this again suggests that the transcrip-
tional state of the gene is important for hypermutation.
Yelamos et al. [12] have recently added yet another piece
to the hypermutation puzzle. Using the same K construct
as Betz et al. [11], they removed the VJ coding region of
the transgene and replaced it with similar-size inserts of
the bacterial neo gene, the bacterial gpt gene or the human
P-globin gene (Fig. 1). In a step which wisely conserved
both time and money, they constructed a transgenic
mouse that contained not only the neo and the gpt variant
constructs, but also a previously-tested K transgene as a
positive control for hypermutation. In a second line of
mice, they inserted the human 1-globin gene alone.
The transgene sequences for analysis of hypermutation
were amplified, using the polymerase chain reaction
(PCR), either directly from germinal-center B cells from
Peyer's patches - lymphoid follicles on the small intestine
- or from hybridomas. The first approach allowed for
the rapid recovery and analysis of many transgenes; and
the second permitted a more detailed analysis of the three
different transgenes coexisting in the same cell. The two
approaches gave the same results. The VJ coding region
could be replaced, even by a bacterial gene, without dis-
rupting hypermutation of the normally targeted area.
Thus there is nothing unique about the coding region of
the variable gene that targets hypermutation to it.
Analysis of the mutations indicated that, as is typical of
somatic hypermutation, most were single-base substitu-
tions, with a bias towards transitions over transversions.
Also, in support of these same authors' earlier theory
[11], there appear to be several mutation hotspots in the
gpt and -globin transgenes. These hotspots center
around a triplet that is either AGC or AGT, both of
which, in frame, code for a serine residue. Such hotspots
suggest that the mutation mechanism may recognize local
DNA structure in the coding region [13]. Hotspots have
not, however, been found in the heavily mutated 5' and
3' nontranslated regions flanking the V(D)J gene [2,14].
This suggests that, while AGC/T may be a highly
susceptible substrate for mutation, recognition of a sub-
strate by the hypermutation machinery requires more
than a simple sequence motif. Strand discrimination,
where the four bases are not mutated equally on both
strands, was also observed on the -globin and neo-sub-
stituted transgenes, although the exact pattern varied
from that seen in V(D)J genes. The target sequence must
therefore play a role in determining the type of mutation.
As clear as these results seem, not every sequence placed
downstream of an immunoglobulin gene promoter will
necessarily undergo hypermutation. At the Ninth Inter-
national Congress on Immunology in July, there were
three independent reports of results differing from those
of Yelamos et al. [12]. Ursula Storb's group (University of
Chicago) placed a second immunoglobulin promoter just
upstream of the C coding region, and observed six-fold
lower mutation in the area. Tim Manser's group (Thomas
Jefferson University) substituted the CD72 gene for the
VJ coding region, and did not find hypermutation of the
transgenes in hybridomas from transgenic mice. Finally,
our group placed 2 kb of bacteriophage DNA down-
stream of the promoter in a K transgene, and did not
detect hypermutation of the X DNA sequence. Clearly,
these results muddy the waters. The results of Yelamos et
al. [12] nevertheless add an exciting piece to the puzzle
of hypermutation, and may help fit a few more of the
pieces together. We can now begin to close in on the cis
DNA sequences that target hypermutation with such
exquisite specificity, and start to hunt in earnest for the
molecular machinery that creates these extraordinary
mutations.
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